Division of Biomedical Imaging, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, United Kingdom.
Leiden University Medical Centre, Leiden, The Netherlands.
Int J Cardiol. 2017 Dec 15;249:486-493. doi: 10.1016/j.ijcard.2017.07.023. Epub 2017 Sep 28.
Four-dimensional flow cardiovascular magnetic resonance (4D flow CMR) is an emerging non-invasive imaging technology used to visualise and quantify intra-cardiac blood flow. The aim of this systematic review is to assess the literature on the current clinical applications of intra-cardiac 4D flow CMR.
A systematic review was conducted to evaluate the literature on the intra-cardiac clinical applications of 4D flow CMR. Structured searches were carried out on Medline, EMBASE and the Cochrane Library in October 2016. A modified Critical Skills Appraisal Programme (CASP) tool was used to objectively assess and score the included studies. Studies were categorised as 'highly clinically applicable' for scores of 67-100%, 'potentially clinically applicable' for 34-66% and 'less clinically applicable' for 0-33%.
Of the 1608 articles screened, 44 studies met eligibility for systematic review. The included literature consisted of 22 (50%) mechanistic studies, 18 (40.9%) pilot studies and 4 (9.1%) diagnostic studies. Based on the modified CASP tool, 27 (62%) studies were 'highly clinically applicable', 9 (20%) were 'potentially clinically applicable' and 8 (18%) were 'less clinically applicable'.
There are many proposed methods for using 4D flow CMR to quantify intra-cardiac flow. The evidence base is mainly mechanistic, featuring single-centred designs. Larger, multi-centre studies are required to validate the proposed techniques and investigate the clinical advantages that 4D flow CMR offers over standard practices. PROSPERO=CRD42016051438.
四维血流心血管磁共振(4D flow CMR)是一种新兴的非侵入性成像技术,用于可视化和量化心内血流。本系统评价的目的是评估心内 4D flow CMR 的当前临床应用文献。
系统检索了 2016 年 10 月在 Medline、EMBASE 和 Cochrane Library 上发表的关于 4D flow CMR 心内临床应用的文献。使用改良的关键技能评估计划(CASP)工具客观评估和评分纳入的研究。研究分为 67-100%为“高度临床适用”,34-66%为“可能临床适用”,0-33%为“较少临床适用”。
在筛选出的 1608 篇文章中,有 44 篇符合系统评价的纳入标准。纳入的文献包括 22 项(50%)机制研究、18 项(40.9%)试验研究和 4 项(9.1%)诊断研究。根据改良的 CASP 工具,27 项(62%)研究为“高度临床适用”,9 项(20%)为“可能临床适用”,8 项(18%)为“较少临床适用”。
有许多使用 4D flow CMR 量化心内血流的方法。证据基础主要是机制研究,采用单中心设计。需要更大规模的多中心研究来验证提出的技术,并研究 4D flow CMR 相对于标准实践提供的临床优势。PROSPERO=CRD42016051438。